Excerpts from the interview In the context of emerging markets in APAC, what are some of the opportunities and challeng...
Innovent Biologics, a world-class China-based biopharmaceutical company that develops and commercializes high quality dr...
The Center for Information and Study on Clinical Research Participation (CISCRP), a Boston-based nonprofit organization,...
Three groundbreaking papers published in New England Journal of Medicine, led by a team of Monash University researchers...
Medtronic has initiated a new clinical study in patients implanted with its Resolute Onyx drug-eluting stent (DES) durin...
Oryzon Genomics, a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseas...
TB Alliance, a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight...
Singapore - An in-depth study on the regulation of adenosine-to-inosine (A-to-I) RNA editing by researchers from the Can...
Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologi...
Lion TCR Pte. Ltd., a Singapore-based Biotech company has received approval from Health Sciences Authority (HSA), Singap...
FSD Pharma announced the launch of a clinical research collaborative program in Israel, via its strategic R&D p...
Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) has announced that results of the global Phase 3 MAVORIC study (Mogamulizumab...
Ascletis announced that the Ganovo phase III clinical study won the top clinical research award at the 15th National Con...
Singapore- Immunomedics, a biopharmaceutical company in the area of antibody-drug conjugates (ADC), announced a co...
SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders, has announced that it has been aw...
Singapore- Merck, a leading science and technology company, announced that the German Federal Institute for Drugs and Me...
Innovent Biologics, a world-class China-based biopharmaceutical company that develops and intends to commercialize high ...
A recent article in the Annals of Emergency Medicine reported on the diagnostic accuracy of the newly released Beckman C...
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec, and Antengene Corporation, a biopharmaceutical company, recen...
Puma Biotechnology, Inc., a biopharmaceutical company, and Strata Oncology, Inc., a precision oncology company, have ent...
Eisai Co., Ltd. announces that a total of 13 presentations highlighting results from a Phase II clinical study (Study 20...
About 20,000 people in the United States are living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's...
Northlane Capital Partners has announced that it has made an investment in Firma Clinical Research (“Firma”)...
The Health Sciences Authority has approved Novartis Kisqali (Ribociclib, LEE011), earlier this year as a first-line trea...
Singapore – Scientists from A*STAR’s Institute of Molecular & Cell Biology (IMCB) have discovered a key ...
